+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Global Point-of-Care Glucose Testing Market by Product (Accu Check Aviva Meter, Accu-Chek Inform II, Bayer Contour Blood Glucose Monitoring System), Mode of Purchase (OTC Testing Product, Prescription-Based Testing Product), End-User - Forecast 2024-2030

  • PDF Icon

    Report

  • 185 Pages
  • January 2024
  • Region: Global
  • 360iResearch™
  • ID: 5305543
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Point-of-Care Glucose Testing Market size was estimated at USD 6.70 billion in 2023, USD 7.20 billion in 2024, and is expected to grow at a CAGR of 7.54% to reach USD 11.15 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Point-of-Care Glucose Testing Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Point-of-Care Glucose Testing Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Point-of-Care Glucose Testing Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Accubiotech Co. Ltd., ACON Laboratories, Inc. by Inverness Medical Innovations, Inc., Bio-Rad Laboratories, Danaher Corporation, EKF Diagnostics by IBL PLC, F. Hoffmann-La Roche Ltd., Fluxergy, LifeScan, Inc., Medtronic PLC, Nipro Corporation, Nova Biomedical Corporation, Prodigy Diabetes Care, LLC., Siemens Healthineers AG, and Sinocare.

Market Segmentation & Coverage

This research report categorizes the Point-of-Care Glucose Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product
    • Accu Check Aviva Meter
    • Accu-Chek Inform II
    • Bayer Contour Blood Glucose Monitoring System
    • Freestyle Lite
    • i-STAT
    • Onetouch Verio Flex
    • StatStrip
    • True Metrix
  • Mode of Purchase
    • OTC Testing Product
    • Prescription-Based Testing Product
  • End-User
    • Home Care Settings
    • Hospitals & Critical Care Centers
    • Outpatient & Ambulatory Care Facilities
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

  1. What is the market size and forecast of the Point-of-Care Glucose Testing Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Point-of-Care Glucose Testing Market?
  3. What are the technology trends and regulatory frameworks in the Point-of-Care Glucose Testing Market?
  4. What is the market share of the leading vendors in the Point-of-Care Glucose Testing Market?
  5. Which modes and strategic moves are suitable for entering the Point-of-Care Glucose Testing Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Frequently Asked Questions about the Global Point-of-Care Glucose Testing Market

What is the estimated value of the Global Point-of-Care Glucose Testing Market?

The Global Point-of-Care Glucose Testing Market was estimated to be valued at $7.2 Billion in 2024.

What is the growth rate of the Global Point-of-Care Glucose Testing Market?

The growth rate of the Global Point-of-Care Glucose Testing Market is 7.5%, with an estimated value of $11.15 Billion by 2030.

What is the forecasted size of the Global Point-of-Care Glucose Testing Market?

The Global Point-of-Care Glucose Testing Market is estimated to be worth $11.15 Billion by 2030.

Who are the key companies in the Global Point-of-Care Glucose Testing Market?

Key companies in the Global Point-of-Care Glucose Testing Market include Abbott Laboratories, Accubiotech Co. Ltd., ACON Laboratories, Inc. by Inverness Medical Innovations, Inc., Bio, Rad Laboratories, Danaher Corporation, EKF Diagnostics by IBL PLC, F. Hoffmann, La Roche Ltd. and Fluxergy.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Point-of-Care Glucose Testing Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increase in the prevalence rate of diabetic patients
5.1.1.2. Growing incorporation of data management programs in the monitoring of glucose
5.1.1.3. Growing demand for home healthcare from developed and developing countries
5.1.2. Restraints
5.1.2.1. High cost of product development
5.1.3. Opportunities
5.1.3.1. Integration of digital technologies for better testing
5.1.3.2. Expansion of supply chain and distribution networks
5.1.4. Challenges
5.1.4.1. Potential interference and calibration issues in glucose meters
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Point-of-Care Glucose Testing Market, by Product
6.1. Introduction
6.2. Accu Check Aviva Meter
6.3. Accu-Chek Inform II
6.4. Bayer Contour Blood Glucose Monitoring System
6.5. Freestyle Lite
6.6. i-STAT
6.7. Onetouch Verio Flex
6.8. StatStrip
6.9. True Metrix
7. Point-of-Care Glucose Testing Market, by Mode of Purchase
7.1. Introduction
7.2. OTC Testing Product
7.3. Prescription-Based Testing Product
8. Point-of-Care Glucose Testing Market, by End-User
8.1. Introduction
8.2. Home Care Settings
8.3. Hospitals & Critical Care Centers
8.4. Outpatient & Ambulatory Care Facilities
9. Americas Point-of-Care Glucose Testing Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Point-of-Care Glucose Testing Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Point-of-Care Glucose Testing Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player
13. Competitive Portfolio
13.1. Key Company Profiles
13.1.1. Abbott Laboratories
13.1.2. Accubiotech Co. Ltd.
13.1.3. ACON Laboratories, Inc. by Inverness Medical Innovations, Inc.
13.1.4. Bio-Rad Laboratories
13.1.5. Danaher Corporation
13.1.6. EKF Diagnostics by IBL PLC
13.1.7. F. Hoffmann-La Roche Ltd.
13.1.8. Fluxergy
13.1.9. LifeScan, Inc.
13.1.10. Medtronic PLC
13.1.11. Nipro Corporation
13.1.12. Nova Biomedical Corporation
13.1.13. Prodigy Diabetes Care, LLC.
13.1.14. Siemens Healthineers AG
13.1.15. Sinocare
13.2. Key Product Portfolio
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing
List of Figures
FIGURE 1. POINT-OF-CARE GLUCOSE TESTING MARKET RESEARCH PROCESS
FIGURE 2. POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, 2023 VS 2030
FIGURE 3. POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. POINT-OF-CARE GLUCOSE TESTING MARKET DYNAMICS
FIGURE 7. POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 8. POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2023 VS 2030 (%)
FIGURE 10. POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 12. POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. POINT-OF-CARE GLUCOSE TESTING MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 22. POINT-OF-CARE GLUCOSE TESTING MARKET SHARE, BY KEY PLAYER, 2023
List of Tables
TABLE 1. POINT-OF-CARE GLUCOSE TESTING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 6. POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY ACCU CHECK AVIVA METER, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY ACCU-CHEK INFORM II, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY BAYER CONTOUR BLOOD GLUCOSE MONITORING SYSTEM, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY FREESTYLE LITE, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY I-STAT, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY ONETOUCH VERIO FLEX, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY STATSTRIP, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY TRUE METRIX, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2018-2030 (USD MILLION)
TABLE 15. POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY OTC TESTING PRODUCT, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRESCRIPTION-BASED TESTING PRODUCT, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 18. POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY HOSPITALS & CRITICAL CARE CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY OUTPATIENT & AMBULATORY CARE FACILITIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. AMERICAS POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 22. AMERICAS POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2018-2030 (USD MILLION)
TABLE 23. AMERICAS POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 24. AMERICAS POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 25. ARGENTINA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 26. ARGENTINA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2018-2030 (USD MILLION)
TABLE 27. ARGENTINA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 28. BRAZIL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 29. BRAZIL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2018-2030 (USD MILLION)
TABLE 30. BRAZIL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 31. CANADA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 32. CANADA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2018-2030 (USD MILLION)
TABLE 33. CANADA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 34. MEXICO POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 35. MEXICO POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2018-2030 (USD MILLION)
TABLE 36. MEXICO POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 37. UNITED STATES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 38. UNITED STATES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2018-2030 (USD MILLION)
TABLE 39. UNITED STATES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 40. UNITED STATES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 41. ASIA-PACIFIC POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 42. ASIA-PACIFIC POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2018-2030 (USD MILLION)
TABLE 43. ASIA-PACIFIC POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 44. ASIA-PACIFIC POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 45. AUSTRALIA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 46. AUSTRALIA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2018-2030 (USD MILLION)
TABLE 47. AUSTRALIA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 48. CHINA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 49. CHINA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2018-2030 (USD MILLION)
TABLE 50. CHINA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 51. INDIA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 52. INDIA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2018-2030 (USD MILLION)
TABLE 53. INDIA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 54. INDONESIA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 55. INDONESIA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2018-2030 (USD MILLION)
TABLE 56. INDONESIA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 57. JAPAN POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 58. JAPAN POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2018-2030 (USD MILLION)
TABLE 59. JAPAN POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 60. MALAYSIA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 61. MALAYSIA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2018-2030 (USD MILLION)
TABLE 62. MALAYSIA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 63. PHILIPPINES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 64. PHILIPPINES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2018-2030 (USD MILLION)
TABLE 65. PHILIPPINES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 66. SINGAPORE POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 67. SINGAPORE POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2018-2030 (USD MILLION)
TABLE 68. SINGAPORE POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 69. SOUTH KOREA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 70. SOUTH KOREA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2018-2030 (USD MILLION)
TABLE 71. SOUTH KOREA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 72. TAIWAN POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 73. TAIWAN POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2018-2030 (USD MILLION)
TABLE 74. TAIWAN POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 75. THAILAND POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 76. THAILAND POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2018-2030 (USD MILLION)
TABLE 77. THAILAND POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 78. VIETNAM POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 79. VIETNAM POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2018-2030 (USD MILLION)
TABLE 80. VIETNAM POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 81. EUROPE, MIDDLE EAST & AFRICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 82. EUROPE, MIDDLE EAST & AFRICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2018-2030 (USD MILLION)
TABLE 83. EUROPE, MIDDLE EAST & AFRICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 84. EUROPE, MIDDLE EAST & AFRICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 85. DENMARK POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 86. DENMARK POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2018-2030 (USD MILLION)
TABLE 87. DENMARK POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 88. EGYPT POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 89. EGYPT POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2018-2030 (USD MILLION)
TABLE 90. EGYPT POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 91. FINLAND POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 92. FINLAND POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2018-2030 (USD MILLION)
TABLE 93. FINLAND POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 94. FRANCE POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 95. FRANCE POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2018-2030 (USD MILLION)
TABLE 96. FRANCE POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 97. GERMANY POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 98. GERMANY POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2018-2030 (USD MILLION)
TABLE 99. GERMANY POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 100. ISRAEL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 101. ISRAEL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2018-2030 (USD MILLION)
TABLE 102. ISRAEL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 103. ITALY POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 104. ITALY POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2018-2030 (USD MILLION)
TABLE 105. ITALY POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 106. NETHERLANDS POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 107. NETHERLANDS POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2018-2030 (USD MILLION)
TABLE 108. NETHERLANDS POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 109. NIGERIA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 110. NIGERIA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2018-2030 (USD MILLION)
TABLE 111. NIGERIA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 112. NORWAY POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 113. NORWAY POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2018-2030 (USD MILLION)
TABLE 114. NORWAY POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 115. POLAND POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 116. POLAND POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2018-2030 (USD MILLION)
TABLE 117. POLAND POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 118. QATAR POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 119. QATAR POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2018-2030 (USD MILLION)
TABLE 120. QATAR POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 121. RUSSIA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 122. RUSSIA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2018-2030 (USD MILLION)
TABLE 123. RUSSIA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 124. SAUDI ARABIA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 125. SAUDI ARABIA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2018-2030 (USD MILLION)
TABLE 126. SAUDI ARABIA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 127. SOUTH AFRICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 128. SOUTH AFRICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2018-2030 (USD MILLION)
TABLE 129. SOUTH AFRICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 130. SPAIN POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 131. SPAIN POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2018-2030 (USD MILLION)
TABLE 132. SPAIN POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 133. SWEDEN POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 134. SWEDEN POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2018-2030 (USD MILLION)
TABLE 135. SWEDEN POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 136. SWITZERLAND POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 137. SWITZERLAND POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2018-2030 (USD MILLION)
TABLE 138. SWITZERLAND POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 139. TURKEY POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 140. TURKEY POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2018-2030 (USD MILLION)
TABLE 141. TURKEY POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 142. UNITED ARAB EMIRATES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 143. UNITED ARAB EMIRATES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2018-2030 (USD MILLION)
TABLE 144. UNITED ARAB EMIRATES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 145. UNITED KINGDOM POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 146. UNITED KINGDOM POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2018-2030 (USD MILLION)
TABLE 147. UNITED KINGDOM POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 148. POINT-OF-CARE GLUCOSE TESTING MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 149. POINT-OF-CARE GLUCOSE TESTING MARKET SHARE, BY KEY PLAYER, 2023
TABLE 150. POINT-OF-CARE GLUCOSE TESTING MARKET LICENSE & PRICING

Companies Mentioned

  • Abbott Laboratories
  • Accubiotech Co. Ltd.
  • ACON Laboratories, Inc. by Inverness Medical Innovations, Inc.
  • Bio-Rad Laboratories
  • Danaher Corporation
  • EKF Diagnostics by IBL PLC
  • F. Hoffmann-La Roche Ltd.
  • Fluxergy
  • LifeScan, Inc.
  • Medtronic PLC
  • Nipro Corporation
  • Nova Biomedical Corporation
  • Prodigy Diabetes Care, LLC.
  • Siemens Healthineers AG
  • Sinocare

Methodology

Loading
LOADING...